1. 10 Performance of SLEDAI-2K Responder Index-50 in a Randomized Placebo-Controlled Trial with Ustekinumab (UST) in Systemic Lupus Erythematosus. (April 2019) Authors: Touma, Zahi; Gladman, Dafna D; Fei, Kaiyin; Irene Gregan, Y; Gordon, Robert; Lo, Kim Hung; Rose, Shawn; Urowitz, Murray B Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO‐MORE study. (26th July 2016) Authors: Pal, Sarvajeet; Veeravalli, Sarath Chandra Mouli; Das, Siddharth Kumar; Shobha, Vineeta; Uppuluri, Ramakrishna Rao; Dharmanand, B G; Nadkar, Milind; Hsia, Elizabeth; Fei, Kaiyin; Yao, Ruji; Khalifa, Ahmed Journal: International journal of rheumatic diseases Issue: Volume 19:Number 11(2016) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety results from a Phase 3, randomized, placebo‐controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy. (11th August 2015) Authors: Li, Zhanguo; Zhang, Fengchun; Kay, Jonathan; Fei, Kaiyin; Han, Chenglong; Zhuang, Yanli; Wu, Zhong; Hsia, Elizabeth C. Journal: International journal of rheumatic diseases Issue: Volume 19:Number 11(2016) Page Start: 1143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Investigating sirukumab for rheumatoid arthritis: 2-year results from the phase III SIRROUND-D study. Issue 2 (16th November 2018) Authors: Thorne, Carter; Takeuchi, Tsutomu; Karpouzas, George Athanasios; Sheng, Shihong; Kurrasch, Regina; Fei, Kaiyin; Hsu, Benjamin Journal: RMD open Issue: Volume 4:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double‐Blind, Placebo‐Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus. Issue 5 (1st April 2020) Authors: van Vollenhoven, Ronald F.; Hahn, Bevra H.; Tsokos, George C.; Lipsky, Peter; Fei, Kaiyin; Gordon, Robert M.; Gregan, Irene; Lo, Kim Hung; Chevrier, Marc; Rose, Shawn Journal: Arthritis & rheumatology Issue: Volume 72:Issue 5(2020) Page Start: 761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0041 MAINTENANCE OF EFFICACY AND SAFETY AND REDUCTION OF BILAG FLARES WITH USTEKINUMAB, AN INTERLEUKIN-12/23 INHIBITOR, IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): 1-YEAR RESULTS OF A PHASE 2, RANDOMIZED PLACEBO-CONTROLLED, CROSSOVER STUDY. (June 2019) Authors: Vollenhoven, Ronald van; Tsokos, George; Gordon, Robert; Lo, Kim Hung; Irene Gregan, Y; Fei, Kaiyin; Rose, Shawn; Hahn, Bevra H. Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus. Issue 11 (7th July 2022) Authors: van Vollenhoven, Ronald F; Kalunian, Kenneth C; Dörner, Thomas; Hahn, Bevra H; Tanaka, Yoshiya; Gordon, Robert M; Shu, Cathye; Fei, Kaiyin; Gao, Sheng; Seridi, Loqmane; Gallagher, Patrick; Lo, Kim Hung; Berry, Pamela; Zuraw, Qing C Journal: Annals of the rheumatic diseases Issue: Volume 81:Issue 11(2022) Page Start: 1556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study. Issue 12 (30th August 2017) Authors: Takeuchi, Tsutomu; Thorne, Carter; Karpouzas, George; Sheng, Shihong; Xu, Weichun; Rao, Ravi; Fei, Kaiyin; Hsu, Benjamin; Tak, Paul P Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 12(2017) Page Start: 2001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. THU0250 EARLY IMPROVEMENT IN SLEDAI-2K RESPONDER INDEX-50 PREDICTS SRI-4 RESPONSE IN A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF USTEKINUMAB (UST) IN SYSTEMIC LUPUS ERYTHEMATOSUS. (June 2019) Authors: Touma, Zahi; Gladman, Dafna D; Rose, Shawn; Fei, Kaiyin; Irene Gregan, Y; Gordon, Robert; Lo, Kim Hung; Urowitz, Murray B Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗